What Cancer Patients Aren’t Talking About
During your doctor visits, there are some things you may not want to bring up. You may think they’re concerns your doctor can't help you with, or maybe you’re embarrassed to talk about them. Recent research looked at what topics cancer patients are willing to discuss with their doctors.
Wait, I Didn’t Know That About Blood Cancer!
Since there is no screening test for blood cancers, early detection is a challenge. But advances in blood cancer treatments are helping patients live longer, more fulfilling lives.
The Long and Winding Cancer Road
Treatments for cancers afflicting young people have improved vastly over the years. For example, survival rates have never been higher for Hodgkin lymphoma, one of the most common cancers in young adults.
Rx Treats the Gut, but Upsets the Blood
Patients with ulcerative colitis can be treated effectively with a class of medications called thiopurines . But taking these medications over a long period of time can have some negative effects.
Gut Feeling About Cancer
In patients with celiac disease, the immune system attacks the patient's own body and causes damage to the lining of the gut. The disease has been linked to a higher risk of lymphoma, a type of blood cancer.
Industrial Pollution Not Just Dirty
Benzene is a chemical that’s used in the making of all sorts of products, ranging from plastics to detergents. It’s also a chemical that’s been linked to blood cancers.
FDA Approves Lenalidomide
On June 5, 2013, the US Food and Drug Administration approved lenalidomide capsules (REVLIMID, Celgene Corporation), for the treatment of patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.
These Cells Can Stem Blood Cancer
Being diagnosed with leukemia or lymphoma can be a major life change for patients. With new advances in medicine, they may have some respite.
Non-Hodgkin Rx Trial Halted
A new medication that was thought to hold promise for non-Hodgkin lymphoma has been stopped. Pfizer announced it has halted its trial of the investigational compound inotuzumab ozogamicin.
Back to Hospital after Stem Cell Transplant
Stem cell transplants can – and do – save the lives of very sick kids. New research has discovered that the transplant is often just the start of hospital stays for these young patients.